NewSquare Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-366
| Closed | -$28.6K | – | 524 |
|
|
2025
Q2 | $28.6K | Buy |
366
+134
| +58% | +$9.99K | ﹤0.01% | 401 |
|
|
2025
Q1 | $16.8K | Buy |
232
+181
| +355% | +$13K | ﹤0.01% | 404 |
|
|
2024
Q4 | $3.78K | Buy |
+51
| New | +$3.57K | ﹤0.01% | 408 |
|
|
2024
Q1 | – | Sell |
-100
| Closed | -$7.63K | – | 468 |
|
|
2023
Q4 | $7.63K | Buy |
+100
| New | +$6.96K | ﹤0.01% | 291 |
|
|
2022
Q1 | – | Sell |
-75
| Closed | -$10K | – | 404 |
|
|
2021
Q4 | $10K | Hold |
75
| – | – | ﹤0.01% | 281 |
|
|
2021
Q3 | $8K | Hold |
75
| – | – | ﹤0.01% | 283 |
|
|
2021
Q2 | $8K | Hold |
75
| – | – | ﹤0.01% | 274 |
|
|
2021
Q1 | $6K | Hold |
75
| – | – | ﹤0.01% | 271 |
|
|
2020
Q4 | $7K | Buy |
+75
| New | +$6.22K | ﹤0.01% | 260 |
|
|
2019
Q1 | – | Sell |
-201
| Closed | -$10K | – | 332 |
|
|
2018
Q4 | $10K | Hold |
201
| – | – | ﹤0.01% | 223 |
|
|
2018
Q3 | $12K | Hold |
201
| – | – | ﹤0.01% | 232 |
|
|
2018
Q2 | $10K | Hold |
201
| – | – | ﹤0.01% | 238 |
|
|
2018
Q1 | $9K | Sell |
201
-198
| -50% | -$8.6K | ﹤0.01% | 236 |
|
|
2017
Q4 | $15K | Sell |
399
-201
| -34% | -$7.38K | ﹤0.01% | 212 |
|
|
2017
Q3 | $22K | Hold |
600
| – | – | 0.01% | 175 |
|
|
2017
Q2 | $24K | Hold |
600
| – | – | 0.01% | 159 |
|
|
2017
Q1 | $19K | Hold |
600
| – | – | ﹤0.01% | 174 |
|
|
2016
Q4 | $19K | Hold |
600
| – | – | ﹤0.01% | 187 |
|
|
2016
Q3 | $24K | Hold |
600
| – | – | 0.01% | 193 |
|
|
2016
Q2 | $20K | Hold |
600
| – | – | ﹤0.01% | 217 |
|
|
2016
Q1 | $18K | Hold |
600
| – | – | 0.01% | 236 |
|
|
2015
Q4 | $16K | Hold |
600
| – | – | ﹤0.01% | 212 |
|
|
2015
Q3 | $14K | Hold |
600
| – | – | ﹤0.01% | 209 |
|
|
2015
Q2 | $14K | Hold |
600
| – | – | ﹤0.01% | 224 |
|
|
2015
Q1 | $14K | Hold |
600
| – | – | ﹤0.01% | 212 |
|
|
2014
Q4 | $13K | Hold |
600
| – | – | ﹤0.01% | 226 |
|
|
2014
Q3 | $10K | Hold |
600
| – | – | ﹤0.01% | 243 |
|
|
2014
Q2 | $9K | Hold |
600
| – | – | ﹤0.01% | 222 |
|
|
2014
Q1 | $7K | Hold |
600
| – | – | ﹤0.01% | 214 |
|
|
2013
Q4 | $7K | Hold |
600
| – | – | ﹤0.01% | 202 |
|
|
2013
Q3 | $7K | Hold |
600
| – | – | ﹤0.01% | 180 |
|
|
2013
Q2 | $7K | Buy |
+600
| New | +$7.1K | ﹤0.01% | 161 |
|
Other funds holding EW
NewSquare Capital's EW Position: Q3 2025 in Review
NewSquare Capital sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 366 shares — an estimated $28.6K sold.
NewSquare Capital first reported a position in EW in Q2 2013 and held it in 32 quarters. The position peaked at $28.6K in Q2 2025. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.
- NewSquare Capital reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
- NewSquare Capital sold 366 Edwards Lifesciences shares in Q3 2025, an estimated $28.6K.
- NewSquare Capital first reported a position in Edwards Lifesciences in Q2 2013 and held it in 32 quarters.
- NewSquare Capital's Edwards Lifesciences position peaked at $28.6K in Q2 2025.
- 1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.
Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.